Literature DB >> 16273630

Research progress of vasculopathy in portal hypertension.

Tao Li1, Zhen Yang.   

Abstract

Portal hypertension, one of the vascular diseases, not only has lesions in liver, but also changes in vascular structures and functions of extrahepatic portal system, systemic system and pulmonary circulation. The pathological changes of vasculopathy in portal hypertension include remodeling of arterialized visceral veins, intimal injury of visceral veins and destruction of contractile structure in visceral arterial wall. The mechanisms of vasculopathy in portal hypertension may be attributed to the changes of hemodynamics in portal system, immune response, gene modulation, vasoactive substances, and intrahepatic blood flow resistance. Portal hypertension can cause visceral hyperdynamic circulation, and the development and progression of visceral vasculopathy, while visceral vasculopathy can promote the development and progression of portal hypertension and visceral hyperdynamic circulation in turn. The aforementioned three factors interact in the pathogenesis of hepatic cirrhosis-induced portal hypertension and are involved in hemorrhage due to varicose vein rupture.

Entities:  

Mesh:

Year:  2005        PMID: 16273630      PMCID: PMC4436622          DOI: 10.3748/wjg.v11.i39.6079

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

1.  Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites.

Authors:  M Morales-Ruiz; W Jiménez; D Pérez-Sala; J Ros; A Leivas; S Lamas; F Rivera; V Arroyo
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

Review 2.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation.

Authors:  S Sasu; D LaVerda; N Qureshi; D T Golenbock; D Beasley
Journal:  Circ Res       Date:  2001-08-03       Impact factor: 17.367

4.  Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension.

Authors:  Q Yu; R Shao; H S Qian; S E George; D C Rockey
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.

Authors:  N Tomita; R Morishita; S Tomita; Y Kaneda; J Higaki; T Ogihara; M Horiuchi
Journal:  Exp Nephrol       Date:  2001

6.  In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.

Authors:  M Van de Casteele; A Omasta; S Janssens; T Roskams; V Desmet; F Nevens; J Fevery
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Collagen synthesis in cultured aortic smooth muscle cells. Modulation by collagen lattice culture, transforming growth factor-beta 1, and epidermal growth factor.

Authors:  W Schlumberger; M Thie; J Rauterberg; H Robenek
Journal:  Arterioscler Thromb       Date:  1991 Nov-Dec

8.  Pathological morphology alteration of the splanchnic vascular wall in portal hypertensive patients.

Authors:  Zhen Yang; Li Zhang; Dapeng Li; Fazu Qiu
Journal:  Chin Med J (Engl)       Date:  2002-04       Impact factor: 2.628

Review 9.  Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding.

Authors:  D Lebrec
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

Review 10.  Molecular biology of hypertension.

Authors:  J E Krieger; V J Dzau
Journal:  Hypertension       Date:  1991-09       Impact factor: 10.190

View more
  4 in total

1.  Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis.

Authors:  Jian Liang; Xin Deng; Zhi-Xiu Lin; Li-Chun Zhao; Xi-Liu Zhang
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

2.  Monitoring the Progression of Chronic Liver Damage in Rats Using [18F]PBR06.

Authors:  Shuo Huang; Chao Li; Jun Guo; Linlin Zhang; Shuqi Wu; Hui Wang; Sheng Liang
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

3.  Detection of liver and spleen stiffness in rats with portal hypertension by two-dimensional shear wave elastography.

Authors:  YongJian Chen; JingYun Li; Qin Zhou; GuoRong Lyu; ShiLin Li
Journal:  BMC Med Imaging       Date:  2022-04-13       Impact factor: 1.930

4.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.